All Insights
Exploring the science, practice, and business of medicine.
Search and Filter Insights
Showing 10 out of 474 Insights
-
Cancer Care Delivery: Moving at the Pace of Innovation
Mara Bloom, JD, MS, the executive director of Mass General Cancer Center, discusses the future of cancer care delivery, grappling with cost, and access to clinical trials.
-
Behind the Curtain with Vinny Arora & Nirvani Goolsarran: Bridging Leaders
How leaders can effectively apply their knowledge is discussed in this Harvard Macy Institute blog post.
-
Peer Instruction-A Med Ed Pearl from the 2019 Annual CGEA Conference
MedEdPearls April 2019: How might you use the 7 steps of Peer Instruction to encourage participation and active learning in medical and health professions?
-
Patient Perspective: Linnea Olson, Cancer Activist
Linnea Olson, a lung cancer activist and blogger, discusses terms of respect, patient-centered drug development, and online patient communities.
-
Language Equity is Essential in Outpatient Practice
Unfortunately, in many institutions, interpreter services can no longer accommodate the volume of people with limited English proficiency—particularly for foreign languages less commonly spoken in the world.
-
F.O.C.U.S.E.D on Improving on the Dental Education
A new framework for dental education is explored in this Harvard Macy Institute blog post.
-
Health Systems Science: The future of medical education and the solution to improving health care
The implementation of Health Systems Science is explored in this Harvard Macy Institute blog post.
-
Best Practices for Engaging Physicians in Health Technology
Leaders in health care attempting to implement health technology can benefit from principles that explain the uptake of innovations, map the requirements of overcoming resistance to change, and facilitate the adoption of technology into practice.
-
Cancer Immunotherapy: Chasing a Durable Cure
Justin F. Gainor, MD, director of targeted immunotherapy at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, answers three questions about cancer immunotherapy.
-